These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 16405538)

  • 1. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis.
    Darwish Murad S; Valla DC; de Groen PC; Zeitoun G; Haagsma EB; Kuipers EJ; Janssen HL
    Am J Gastroenterol; 2006 Jan; 101(1):83-90. PubMed ID: 16405538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems.
    Ganger DR; Klapman JB; McDonald V; Matalon TA; Kaur S; Rosenblate H; Kane R; Saker M; Jensen DM
    Am J Gastroenterol; 1999 Mar; 94(3):603-8. PubMed ID: 10086638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budd-Chiari syndrome: illustrated review of current management.
    Horton JD; San Miguel FL; Membreno F; Wright F; Paima J; Foster P; Ortiz JA
    Liver Int; 2008 Apr; 28(4):455-66. PubMed ID: 18339072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome.
    Darwish Murad S; Valla DC; de Groen PC; Zeitoun G; Hopmans JA; Haagsma EB; van Hoek B; Hansen BE; Rosendaal FR; Janssen HL
    Hepatology; 2004 Feb; 39(2):500-8. PubMed ID: 14768004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eighteen years of liver transplantation experience in patients with advanced Budd-Chiari syndrome.
    Ulrich F; Pratschke J; Neumann U; Pascher A; Puhl G; Fellmer P; Weiss S; Jonas S; Neuhaus P
    Liver Transpl; 2008 Feb; 14(2):144-50. PubMed ID: 18236386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transjugular intrahepatic portosystemic stent-shunt (TIPS) as rescue therapy for complete Budd-Chiari syndrome and portal vein thrombosis.
    Opitz T; Buchwald AB; Lorf T; Awuah D; Ramadori G; Nolte W
    Z Gastroenterol; 2003 May; 41(5):413-8. PubMed ID: 12772054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting.
    Zeitoun G; Escolano S; Hadengue A; Azar N; El Younsi M; Mallet A; Boudet MJ; Hay JM; Erlinger S; Benhamou JP; Belghiti J; Valla D
    Hepatology; 1999 Jul; 30(1):84-9. PubMed ID: 10385643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience.
    Rajani R; Melin T; Björnsson E; Broomé U; Sangfelt P; Danielsson A; Gustavsson A; Grip O; Svensson H; Lööf L; Wallerstedt S; Almer SH
    Liver Int; 2009 Feb; 29(2):253-9. PubMed ID: 18694401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paroxysmal nocturnal hemoglobinuria in Budd-Chiari syndrome: findings from a cohort study.
    Hoekstra J; Leebeek FW; Plessier A; Raffa S; Darwish Murad S; Heller J; Hadengue A; Chagneau C; Elias E; Primignani M; Garcia-Pagan JC; Valla DC; Janssen HL;
    J Hepatol; 2009 Oct; 51(4):696-706. PubMed ID: 19664836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor prognosis and limited therapeutic options in patients with Budd-Chiari syndrome and portal venous system thrombosis.
    Mahmoud AE; Helmy AS; Billingham L; Elias E
    Eur J Gastroenterol Hepatol; 1997 May; 9(5):485-9. PubMed ID: 9187882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budd-Chiari syndrome: long-term effect on outcome with transjugular intrahepatic portosystemic shunt.
    Khuroo MS; Al-Suhabani H; Al-Sebayel M; Al Ashgar H; Dahab S; Khan MQ; Khalaf HA
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1494-502. PubMed ID: 16174064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing perspectives in portal vein thrombosis.
    Janssen HL
    Scand J Gastroenterol Suppl; 2000; (232):69-73. PubMed ID: 11232496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic indices for Budd-Chiari syndrome: valid for clinical studies but insufficient for individual management.
    Rautou PE; Moucari R; Escolano S; Cazals-Hatem D; Denié C; Chagneau-Derrode C; Charpignon C; Lédinghen Vd; Grenouillet-Delacre M; Habersetzer F; Nousbaum JB; Denninger MH; Valla DC; Plessier A
    Am J Gastroenterol; 2009 May; 104(5):1140-6. PubMed ID: 19337247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.
    Senzolo M; M Sartori T; Rossetto V; Burra P; Cillo U; Boccagni P; Gasparini D; Miotto D; Simioni P; Tsochatzis E; A Burroughs K
    Liver Int; 2012 Jul; 32(6):919-27. PubMed ID: 22435854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Budd-Chiari syndrome and portal vein thrombosis associated with myeloproliferative disorders: diagnosis and management.
    Brière JB
    Semin Thromb Hemost; 2006 Apr; 32(3):208-18. PubMed ID: 16673275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portosystemic shunt in Budd-Chiari syndrome: long-term survival and factors affecting shunt patency in 25 patients in Western countries.
    Panis Y; Belghiti J; Valla D; Benhamou JP; Fékété F
    Surgery; 1994 Mar; 115(3):276-81. PubMed ID: 8128351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited prothrombotic defects in Budd-Chiari syndrome and portal vein thrombosis: a study from North India.
    Bhattacharyya M; Makharia G; Kannan M; Ahmed RP; Gupta PK; Saxena R
    Am J Clin Pathol; 2004 Jun; 121(6):844-7. PubMed ID: 15198356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scientific publications on portal vein thrombosis and Budd-Chiari syndrome: a global survey of the literature.
    Qi X; Jia J; Ren W; Yang M; De Stefano V; Wang J; Fan D
    J Gastrointestin Liver Dis; 2014 Mar; 23(1):65-71. PubMed ID: 24689099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome.
    Plessier A; Sibert A; Consigny Y; Hakime A; Zappa M; Denninger MH; Condat B; Farges O; Chagneau C; de Ledinghen V; Francoz C; Sauvanet A; Vilgrain V; Belghiti J; Durand F; Valla D
    Hepatology; 2006 Nov; 44(5):1308-16. PubMed ID: 17058215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of severe Budd-Chiari syndrome.
    Xu PQ; Dang XW
    Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):525-8. PubMed ID: 14627513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.